Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study include 384 Participants with diabetic non-proliferative retinopathy Design Method: Randomized, double blind, placebo controlled and multicenter clinical study. Participants treatment for 48 weeks, and main aimed to evaluate the therapeutic effect of tang wang prescription improve degree of retinal microvascular disease of patients with diabetic non-proliferative retinopathy.
Epistemonikos ID: a67dd3c2b5be853cb31690d5160c39ba593acfa1
First added on: May 20, 2024